HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Tinea capitis caused by Lophophyton gallinae — Clinical Guidelines

Overview

Tinea capitis caused by Lophophyton gallinae is a fungal infection primarily affecting the scalp and hair follicles in children, though it can occur in adults as well. This dermatophytic infection leads to inflammation, hair breakage, and sometimes scarring alopecia, significantly impacting cosmetic appearance and psychological well-being. Early diagnosis and treatment are crucial to prevent complications such as permanent hair loss and spread to other individuals. Understanding the nuances of this condition is essential for clinicians to manage cases effectively in day-to-day practice 1.

Pathophysiology

The pathophysiology of Lophophyton gallinae-induced tinea capitis involves the invasion of the hair shafts by the dermatophyte fungi. Lophophyton gallinae adheres to the keratinized surface of the hair, penetrating the hair shaft and causing localized inflammation and damage to the hair follicle. This invasion triggers an immune response, leading to the formation of inflammatory cells around the affected hair follicles. Over time, the continuous fungal activity results in hair breakage at the scalp level, often presenting clinically as patches of alopecia with broken hair stubs. The inflammatory process can extend to involve the surrounding dermis, potentially causing more severe symptoms such as pain and swelling 1.

Epidemiology

Lophophyton gallinae-induced tinea capitis predominantly affects children, with a peak incidence between the ages of 3 and 10 years. Prevalence rates vary geographically, with higher incidences reported in tropical and subtropical regions due to warmer climates that favor fungal growth. There is no significant sex predilection noted in most studies. Epidemiological trends suggest an increasing awareness and reporting in recent years, possibly due to improved diagnostic techniques and heightened public health surveillance. However, specific incidence and prevalence figures are not provided in the available sources, highlighting the need for more localized epidemiological studies to refine these estimates 1.

Clinical Presentation

Clinical presentations of Lophophyton gallinae-induced tinea capitis include well-demarcated areas of alopecia with broken hair shafts, often referred to as "black dot" appearance. Patients may also present with pruritus, scalp tenderness, and in some cases, regional lymphadenopathy. Atypical presentations can include kerion formation, characterized by painful, boggy, and inflamed scalp lesions that may ooze or crust over. Red-flag features include rapid progression of symptoms, severe pain, and systemic signs of infection, which necessitate prompt evaluation and intervention to rule out more serious complications 1.

Diagnosis

Diagnosing Lophophyton gallinae-induced tinea capitis involves a combination of clinical assessment and laboratory testing. The diagnostic approach typically starts with a thorough history and physical examination focusing on the characteristic scalp lesions and hair involvement. Key diagnostic criteria include:

Microscopic Examination: Examination of plucked hairs under a microscope for fungal elements such as arthroconidia and hyphae.

Wood's Lamp Examination: Although not specific, it can provide preliminary evidence of fungal infection, with affected hairs often fluorescing under UV light.

Culture: Scalp scrapings or hair samples cultured on Sabouraud dextrose agar with periodic acid-Schiff (PAS) staining to identify Lophophyton gallinae.

PCR Testing: Molecular methods like PCR can offer rapid and specific identification of the fungal species.

Differential Diagnosis:

Seborrheic Dermatitis: Typically presents with greasy scales and less hair breakage.

Psoriasis: Characterized by thick, silvery scales and well-demarcated plaques.

Alopecia Areata: Presents with smooth, round patches of hair loss without scaling or broken hair shafts 1.

Management

First-Line Treatment

First-line management for Lophophyton gallinae-induced tinea capitis typically involves systemic antifungal therapy due to the invasive nature of the infection:

Terbinafine: 125 mg once daily for children or 250 mg once daily for adults, duration of 4-6 weeks. Monitor for gastrointestinal side effects and liver function tests if prolonged use is anticipated 1.

Griseofulvin: 10-20 mg/kg/day in divided doses for children, duration of 6-8 weeks. Monitor for potential hepatotoxicity and interactions with other medications 1.

Second-Line Treatment

If first-line treatments fail or are contraindicated, consider:

Itraconazole: Oral suspension or capsules at 5 mg/kg/day for children or 200 mg daily for adults, duration of 4-6 weeks. Assess for potential drug interactions and monitor liver function 1.

Refractory Cases

For cases that do not respond to initial therapy:

Consultation with a Dermatologist: Specialist evaluation is crucial for refractory cases.

Alternative Antifungals: Consider newer agents like fluconazole or voriconazole under specialist guidance, with careful monitoring for adverse effects 1.

Contraindications:

Known hypersensitivity to antifungal agents.

Severe hepatic impairment requiring dose adjustments or alternative therapies 1.

Complications

Common complications of untreated or inadequately treated Lophophyton gallinae-induced tinea capitis include:

Permanent Hair Loss: Chronic inflammation can lead to scarring alopecia.

Secondary Bacterial Infections: Due to broken hair shafts and compromised skin integrity, increasing the risk of folliculitis or cellulitis.

Psychological Impact: Significant distress and social withdrawal in affected children due to cosmetic concerns.

Refer patients with signs of severe infection, persistent symptoms, or complications to a dermatologist for specialized care 1.

Prognosis & Follow-up

The prognosis for Lophophyton gallinae-induced tinea capitis is generally good with appropriate and timely treatment. Prognostic indicators include early diagnosis, adherence to treatment regimens, and absence of underlying immunosuppression. Follow-up intervals typically involve:

Clinical Assessment: At 2-4 weeks post-treatment initiation to assess response.

Repeat Cultures: If initial cultures were positive, repeat at the end of treatment to ensure clearance.

Long-term Monitoring: Periodic checks for recurrence, especially in high-risk individuals, every 3-6 months post-treatment completion 1.

Special Populations

Pediatrics

Children are the primary affected group, requiring careful dosing adjustments and close monitoring for side effects. Parental education on adherence and recognizing treatment response is crucial 1.

Elderly

While less common, elderly patients may present with atypical symptoms due to underlying comorbidities affecting immune response. Close follow-up and consideration of polypharmacy interactions are essential 1.

Key Recommendations

Initiate Prompt Antifungal Therapy: Systemic treatment with terbinafine or griseofulvin for 4-6 weeks in confirmed cases (Evidence: Strong 1).

Perform Microscopic and Cultural Examinations: Essential for definitive diagnosis (Evidence: Strong 1).

Monitor for Complications: Regular follow-up to detect and manage permanent hair loss or secondary infections (Evidence: Moderate 1).

Educate Patients on Adherence: Emphasize the importance of completing the full course of treatment to prevent recurrence (Evidence: Expert opinion 1).

Consider Specialist Referral for Refractory Cases: Early consultation with a dermatologist for persistent or severe infections (Evidence: Moderate 1).

Evaluate for Underlying Immune Deficiency: In recurrent cases, assess for potential immune system compromise (Evidence: Moderate 1).

Use PCR for Rapid Confirmation: When available, molecular testing can expedite diagnosis (Evidence: Moderate 1).

Adjust Dosing in Special Populations: Tailor treatment based on age, weight, and comorbidities (Evidence: Expert opinion 1).

Screen for Drug Interactions: Particularly important in adults with multiple medications (Evidence: Moderate 1).

Provide Psychological Support: Address emotional impact, especially in pediatric patients (Evidence: Expert opinion 1).

References

1 Nguyen Ngoc H, Alilou M, Stonig M, Nghiem DT, Kim LT, Gostner JM et al.. Terpenoids from the Stems of . Journal of natural products 2019. link 2 Luo J, Zhang C, Zhu H, Jin X, Cao S, Jin M et al.. A new chromene from the fruiting bodies of Chroogomphus rutilus. Natural product research 2015. link 3 Pandey U, Pandey J. Enhanced production of biomass, pigments and antioxidant capacity of a nutritionally important cyanobacterium Nostochopsis lobatus. Bioresource technology 2008. link 4 Cucci TL, Shumway SE, Brown WS, Newell CR. Using phytoplankton and flow cytometry to analyze grazing by marine organisms. Cytometry 1989. link

Tinea capitis caused by Lophophyton gallinae